Plasmodium falciparum: in vitro drug interaction between chloroquine and enantiomers of amlodipine.

[1]  E. Raftery,et al.  24-hour blood pressure control with the once-daily calcium antagonist amlodipine. , 1991, Journal of cardiovascular pharmacology.

[2]  A. Cowman,et al.  Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum , 1990, Nature.

[3]  Thomas E. Wellems,et al.  Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross , 1990, Nature.

[4]  K. Tanabe,et al.  Plasmodium chabaudi: in vivo effects of Ca2+ antagonists on chloroquine-resistant and chloroquine-sensitive parasites. , 1990, Experimental parasitology.

[5]  R. Ekong,et al.  ANTIHISTAMINIC DRUGS THAT REVERSE CHLOROQUINE RESISTANCE IN PLASMODIUM FALCIPARUM , 1989, The Lancet.

[6]  A. Cowman,et al.  Amplification of the multidrug resistance gene in some chloroquine-resistant isolates of P. falciparum , 1989, Cell.

[7]  C. Wilson,et al.  Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. , 1989, Science.

[8]  Berenbaum Mc.  What is synergy? , 1989, Pharmacological reviews.

[9]  E. Raftery,et al.  24 h blood pressure control with the once daily calcium antagonist, amlodipine. , 1989, British journal of clinical pharmacology.

[10]  A. Bitonti,et al.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine. , 1988, Science.

[11]  Ye Zuguang,et al.  Reversal of chloroquine resistance in falciparum malaria independent of calcium channels. , 1988 .

[12]  D. Warhurst.  Mechanism of chloroquine resistance in malaria. , 1988, Parasitology today.

[13]  H. Ginsburg.  Effect of calcium antagonists on malaria susceptibility to chloroquine. , 1988, Parasitology today.

[14]  C. Peterson,et al.  D‐verapamil and L‐verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro , 1988, International journal of cancer.

[15]  A. Beresford,et al.  The metabolism and pharmacokinetics of amlodipine in humans and animals. , 1988, Journal of cardiovascular pharmacology.

[16]  J. Webster,et al.  Once daily amlodipine in the treatment of mild to moderate hypertension. , 1987, British journal of clinical pharmacology.

[17]  I. Gluzman,et al.  Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. , 1987, Science.

[18]  A. Safa,et al.  Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. , 1987, The Journal of biological chemistry.

[19]  W. Milhous,et al.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. , 1987, Science.

[20]  I. Pastan,et al.  Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. , 1987, The Journal of biological chemistry.

[21]  M. Gwilt,et al.  Calcium Channel Blocking Properties of Amlodipine in Vascular Smooth Muscle and Cardiac Muscle In Vitro: Evidence for Voltage Modulation of Vascular Dihydropyridine Receptors , 1987, Journal of cardiovascular pharmacology.

[22]  J. Arrowsmith,et al.  Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. , 1986, Journal of medicinal chemistry.

[23]  P. Schlesinger,et al.  A perspective on antimalarial action: effects of weak bases on Plasmodium falciparum. , 1986, Biochemical pharmacology.

[24]  J. Riordan,et al.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines , 1985, Nature.

[25]  H. Ginsburg,et al.  Susceptibility of human malaria parasites to chloroquine is pH dependent. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Le bras,et al.  Chloroquine uptake by Plasmodium falciparum-infected human erythrocytes during in vitro culture and its relationship to chloroquine resistance , 1985, Antimicrobial Agents and Chemotherapy.

[27]  M. Eichelbaum,et al.  The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humans. , 1985, American heart journal.

[28]  S. Ranganathan,et al.  Effect of calcium-channel-blocking drugs on lysosomal function in human skin fibroblasts. , 1984, Biochemical pharmacology.

[29]  Album Ma.  A hazard of modern life. , 1983 .

[30]  J. Le bras,et al.  In vitro study of drug sensitivity of Plasmodium falciparum: evaluation of a new semi-micro test. , 1983, The American journal of tropical medicine and hygiene.

[31]  A. Roscher,et al.  Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. , 1983, The Journal of pharmacology and experimental therapeutics.

[32]  S. Snyder,et al.  A unitary mechanism of calcium antagonist drug action. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[33]  T. Tsuruo,et al.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors. , 1982, Cancer research.

[34]  C. Reynolds,et al.  Inhibition of calmodulin-activated cyclic nucleotide phosphodiesterase: multiple binding-sites for tricyclic drugs on calmodulin. , 1982, Biochemical pharmacology.

[35]  V. Rosário.  Cloning of naturally occurring mixed infections of malaria parasites. , 1981, Science.

[36]  B. Weiss,et al.  Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase. , 1979, The Journal of pharmacology and experimental therapeutics.

[37]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[38]  D. Warhurst,et al.  Lysosomes, pH and the Anti-malarial Action of Chloroquine , 1972, Nature.

[39]  C. D. Fitch.  Plasmodium falciparum in Owl Monkeys: Drug Resistance and Chloroquine Binding Capacity , 1970, Science.